J Int Soc Sports Nutr 10(1):6 Li N, Chen S, He Y, Chen Y, Duan X, He W et al (2025) Effects of oral supplementation of beta -hydroxy-beta -methylbutyrate on muscle mass and strength in individuals over the age of 50: a meta-analysis
Changing one without professional guidance can lead to either subtherapeutic levels (wasting medication and money) or supratherapeutic levels (unnecessary side effects and potential complications)
Thus, BED appears to involve GLP-1 dysregulation without consistent endocrine abnormalities, implying that GLP-1 RA therapy works through supraphysiological receptor activation and modulation of central reward circuitry, rather than by correcting a hormonal deficit [55]
Additionally, researchers looked at data in subgroups based on components like age, obesity at baseline, and treatment duration
The early dosing concerns in this guide apply specifically to weekly injectable GLP-1 formulations where the long interval between doses creates the potential for significant overlap
Antiinflammatory actions of glucagon-like peptide-1based therapies beyond metabolic benefits Yifan Ren, et al
